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Drug allergy: diagnosis and management
A Y Y W u
Summary
Drug allergy is one of the most commonly
encountered medical problems in family practice. The
symptoms may range from trivial to life threatening. As
drug use continues to increase, the incidence of drug
allergies will also continue to rise. Many drugs are
available without doctors' prescriptions, which further
increase the risk of fatal reactions. Drug allergy can
become a major problem for patients with the multiple
drug allergy syndrome, and more so with the emergence
of antibiotic resistant organisms that limits the choice of
antibiotics available. This article reviews the current
understanding in the mechanisms of drug allergy, the
management of patients with allergy to commonly used
drugs such as penicillins, NSAIDs, local anaesthetics and
radiocontrast media. After reading this article, the reader
should be able to recognise patients at high risk of
serious drug reactions and to formulate a management
plan for such patients.
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Introduction
Adverse reactions to drugs are important causes
of morb id i ty and mor t a l i t y and are f r equen t ly
encountered in family practice. It has been estimated
that the risk of an allergic reaction for most drugs is
1-3%.' Such reactions might become an important
reason for complaints or even malpractice litigation.
It is therefore important that all doctors who prescribe
medicines should have a basic understanding of this
subject in order to reduce the risk of adverse drug
reactions in their patients. Since the subject of adverse
drug reactions covers an enormous scope, this review
wil l concentrate on immunological ly-mediated drug
reactions since they are often the most dangerous types
of adverse drug reactions.
Adverse drug reactions can be classified into
predictable and unpredictable categories. Predictable
reactions are often caused by the toxic side effects of
drugs, or by the interaction of different drugs. These
reactions occur commonly and are usually related to
the doses of the drugs. For example, bradycardia
caused by (3-blockers and headache caused by nitrates.
Idiosyncratic, allergic and pseudoallergic reactions are
unpredictable reactions. Chloramphenicol-induced
aplastic anaemia is an example of an idiosyncratic
reaction. Only a very small proportion of patients is
affected and the reaction cannot be predicted by animal
testing.
Mechanisms of drug allergies
Allergic reactions have certain characteristics that
help to distinguish them from other types of adverse
drug reactions. These include:
1. Prior sensitisation. Allergic reactions to drugs, like
other immunologically-mediated reactions, are
acquired. In other words, the immune system must
have been exposed to related drugs previously in
order to be sens i t i sed . The l ike l ihood of
sensitisation depends on the genetic predisposition
of the individual, the amount of drug given, and the
length, frequency and route of exposure. Genetic
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predisposition to drug allergies appears not to be
related to other atopic diseases such as asthma,
allergic rhinitis or food allergies. In general, longer
or more frequent exposure will more likely lead to
sensitisation, and cutaneous exposure is more likely
to sensitise than by intravenous route, and oral
administration being the least likely. Some cases
of allergic reactions to drugs given apparently for
the first time may be due to cross-sensitisation or
previous occult exposure, as antibiotic use in animal
fee is widespread in the farming industry.
2. Consistency in symptoms. Allergic reactions lead
to a l imited and we l l - cha rac t e r i s ed set of
symptoms. Different allergic mechanisms lead to
different sets of symptoms that can often be
distinguished clinically. Repeated exposure will
invar iably reproduce s imi lar symptoms in any
given ind iv idua l .
3. The severity of symptoms is often unrelated to the
dose of drug given. Even minute amount of a drug
far below therapeut ic dose can lead to a fatal
reaction. As a result, application of a "test dose"
could be a very dangerous proposition.
4. Temporal relationship. A drug allergy reaction is
always temporally related to drug exposure. The
t iming of the react ion is dependent on the
mechanism of the reaction. For example, an IgE-
mediated reaction usually occurs within 15 minutes
to one hour of exposure.
As most drugs are small molecules incapable of
sensitising the immune system on their own, they act
as haptens by b ind ing to serum prote ins , thereby
al ter ing the an t igen ic determinants . The genetic
predisposition to producing active drug metabolites that
react with serum proteins may affect the likelihood of
becoming sensitised to drugs . Drug allergies may
involve many different immunological mechanisms, but
can be classified along the lines described by Gell and
Coombs:
Type I or Immediate-type hypersensitivity reactions
T cells sensitised to a drug stimulate B cells to
produce antibodies of the IgE isotype against the drug.
During re-exposure, cross-linking of IgE bound to the
surface of mast cells by antigen leads to mast cell
degranulation and the release of mediators such as
histamine, cytokines, proteolytic enzymes, eicosanoids
and platelet activating factor. Symptoms can occur
from 15 minutes to 1 hour after exposure. Symptoms
of a n a p h y l a x i s i n c l u d e genera l i sed u r t i c a r i a ,
angioedema, bronchoconstriction, hypotension or even
cardiovascular collapse. Less severe reactions may
involve the skin only. Examples of drugs causing type
I reactions include penicillin, insulin and streptokinase.
Type n or antibody mediated cellular cytotoxicity
reactions
IgG or IgM antibodies specific for drug antigens
may bind to surface of cells such as erythrocytes ,
platelets or granulocytes. Binding of drug molecules
to the surface bound antibody triggers a cascade of
events involving complement activation, leading to cell
lysis. These reactions may occur hours to days after
exposure . Example may inc lude p e n i c i l l i n and
sulphonamides .
Type III or immune complex mediated reactions
IgG or IgM antibodies specific for drug antigens
bind to drug molecules to form insoluble complexes,
which get deposited in basement membrane of blood
vessels. The classic reaction in this category is serum
sickness characterized by fever, cutaneous eruptions,
lymphadenopathy, arthralgias, nephritis, hepatitis, and
vasculitis. These reactions may occur 4 to 20 days after
exposure.4 Penicillin, anti- thymocyte globulin or
heteroantisera may lead to this type of reactions.
Type IV or Delayed type hypersensitivity reactions
Sensitised T cells may directly damage the target
organ, usually the skin in this type of reactions. A
classic example is contact dermatitis secondary to
topical antibiotics or anaesthetics. The reaction usually
occurs 48 to 72 hours after exposure.
There a re m a n y reac t ions w i t h complex
mechanisms that cannot be neatly classified under one
of these categories. These reactions include Stevens-
Johnson syndrome, erythema multiforme, mobilliform
drug rashes, fixed drug eruptions, toxic epidermal
necrolysis and many organ-specific drug reactions.
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Pseudoallergic reactions
These a re r e a c t i o n s t h a t a re c l i n i c a l l y
indistinguishable from type I reactions. Drugs that
can cause mast cell degranulation directly without
sensitising the immune system include radiocontrast
media, certain muscle relaxants, vancomycin and
opiates. Angiotensin converting enzyme inhibitors can
cause angioedema by accumulating bradykinins. Non-
steroidal ant i - inf lammatory drugs (NSAIDs) may
exacerbate pre-exist ing ur t icar ia l rashes or cause
bronchospasm by altering eicosanoid metabolism. Since
these reactions do not involve immune activation, no
prior sensitisation is required.
Diagnosis of drug allergy
A detailed history is of utmost importance in
diagnosing drug allergies. The symptoms, drug history
and the t i m i n g of r eac t ion in re la t ion to d rug
administration wi l l help to pinpoint the offending drug
and the type of reaction. A previous history of drug
allergies or a fami ly history of drug allergies is
important since these factors greatly predispose the
patient to developing allergies to other drugs.2 Sullivan
suggested that in people allergic to penicil l in, there
was at least a tenfold increase in reaction rate to non-
beta-lactam antibiotics. As mentioned earlier, other
atopic diseases do not predispose the patient to drug
allergies. A history of concomitant illness is also
important. Quite frequently, viral rashes are mistaken
as drug rashes caused by antibiotics given to treat the
viral illness. Drugs given under some circumstances
may also lead to a non-immunologically mediated rash.
For example, ampici l l in /amoxici l l in given during
i n f e c t i o n c a u s e d by E p s t e i n - B a r r v i r u s o r
cytomegalovirus, or when given to a patient with acute
lymphocytic leukaemia, may lead to a drug rash.
Similarly, penicillin given to a patient with syphilis
may lead to the Jarisch-Herxheimer reaction. Under
other circumstances, these patients will not react to
the antibiotics. AIDS also predisposes patients to drug
allergies. Fifty percent of AIDS patients treated with
trimethoprim-sulfamethoxazole develop an allergic
rash.3
Physical examination should focus on the skin,
a frequent site of manifestation of drug allergies. It
is important to distinguish between a mobilliform rash
from an urticaria rash; the former is usually benign
whereas the latter indicates the presence of IgE
antibodies. Direct observation by the physician is
important as patients' description may not be accurate,
as discussed below. Mucosal involvement may indicate
Stevens-Johnson syndrome or toxic epidermal
necrolysis. Both are serious conditions. Chest
examinat ion may reveal wheezing secondary to
bronchospasm, or stridor caused by laryngeal oedema.
Laboratory tests may be helpful in diagnosing
organ-specific allergic reactions such as haemolytic
anaemias, hepat i t i s , nephri t is etc. Anti-his tone
antibodies may appear in patients taking hydralazine
or procainamide, but do not necessarily indicate drug-
induced lupus. In situations where anaphylaxis is
suspected, a serum tryptase level drawn within 3 to 4
hours of the reaction may help; the assay is however
expensive. Skin tests are available for diagnosing
type I reactions to penici l l in and insul in. Radio-
allergosorbent tests (RAST) for penicillin, ampicillin
and cephalosporin specific IgE are available but are
unreliable and tend to over-diagnose allergies.
Management of drug allergies
Penicillin and other (3-lactam antibiotics
(3-lactam antibiotics are some of the most widely
used drugs and are responsible for the majority of drug
allergies. These drugs can cause many different types
of allergic reactions, from minor drug rashes to fatal
anaphylaxis. Fatal reactions are rare, but it is important
to distinguish the serious reactions from the trivial.
One often encounters patients with a vague history of
allergy to penicillin in the past. Mendelson et al. skin-
tested 240 children and adolescents with a history of
penicillin or amoxicillin allergy and found only 8.75%
to be truly allergic to these antibiotics.5 Similarly,
Macy et al. skin-tested 348 patients referred to their
allergy clinic with a history of penicillin allergy, and
only 60 (17.2%) were found to have positive skin tests.6
These results suggest that without skin testing, the
majority of patients labelled as 'penicillin allergic'
would be avoiding these drugs unnecessarily.
Before starting a patient on p-lactam antibiotics,
the physician must ascertain whether the patient is
allergic to the drug, and the seriousness of the allergic
reaction. In general, t r ivial drug rashes are not
contraindications to the use of these drugs if they are
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absolutely needed, since the symptoms of the reaction
can often be managed to allow the patient to complete
the course of treatment. However, these drugs must
be completely avoided if the patient has a history of
Stevens-Johnson syndrome, toxic epidermal necrolysis
or type I hypersensitivity reactions. The first two
entities, both serious conditions, should be easily
recognisable. However, the patient may not be able
to distinguish a mobilliform or maculopapular rash
from an urticarial rash. Pichichero reported that 22%
of patients with a history suggestive of a non-IgE
mediated rash nevertheless had positive skin tests to
penicillin.7
Skin testing has proven to be very reliable in
predicting the risk of anaphylactic reactions. Penicillin
is metabolised to major and minor determinants. The
major de te rminant is p en i c i l l o y l and the minor
determinants inc lude penici l loate , peni l loate and
benzylpenicil l in (Table 1). Skin testing reagent for
the major d e t e r m i n a n t is ava i l ab l e (pen i c i l l oy l
polylysine, PrePen). Although the minor determinants
are responsible for a substantial proportion of serious
anaphylactic reactions, no skin testing reagent for
minor determinants is commercially available. Sodium
amoxicillin is usually included in the panel since some
patients react to its side-chain instead of the p-lactam
group. In Macy's study, 12 out of 60 (20%) penicillin
al lergic pa t ien t s reacted to pen i l l oa t e and /o r
penicilloate only6 (Table 2). When skin testing is
carried out using major and minor determinants and
amoxicillin, a very high negative predictive value is
achieved. In Macy's study, only 5.2% of patients with
negative skin tests developed a reaction on oral
challenge, and all were mild. Skin testing is also safe,
and only 0.3% of patients is known to develop urticaria
during the tests.
Skin tests for penicillin should be by intradermal
injections only, since prick puncture is not sufficiently
sensit ive. Appropriate solutions for skin testing
include penicilloyl polylysine (Schwarz Pharma),
p e n i c i l l o a t e ( 0 . 0 1 M ) , p e n i l l o a t e ( 0 . 0 1 M ) ,
benzylpenici l l in (0.01M) and amoxycillin (0.01M).
Since penicilloate and penilloate are not commercially
available, they must be prepared and stored in the
freezer. 0 .02ml of the solut ions are injected
intradermally and the wheal and flare reaction is read
after 15 minutes. Histamine and saline are used as
positive and negative controls respectively. Positive
Table 1: Skin-test reagents for penicillin allergy
Major determinant
- Penicilloyl polylysine (PrePen) 10-6 M
Minor determinant mix (MDM)
- Potassium penicillin G 0.01M
- Sodium benzylpenicilloate 0.01M
- Benzylpenicilloyl-n-propylamine 0.01M
0.01MSodium amoxicillin
Histamine
Saline control
mg/ml
Table 2: Type and specificity of positive penicillin skin
test reactions in 384 patients
Reagent Puncture Intradermal
(no. of patients)(no. of patients)
PrePen
Penicilloate 2
Penilloate 1
Penicilloate + penilloate
Penicillin + PrePen
Penicillin
Amoxicillin
All other combinations* 3
Total 6
24
2
6
1
6
2
1
12
54
* All of these subjects had positive responses to at least one of the
commercially available skin test materials: amoxicill in (3 of 15),
PrePen (11 of 15), and penicillin (1 of 15).
From:Macy E, Richter PK, Falkoff R, et al. J Allergy Clin Immunol 1997;
100:586-591.
responses consist of a wheal of 5 mm or more in
diameter with surrounding erythema greater than the
wheal, a negative response to control solution and a
positive response to histamine.
The incidence of skin test positivity declines with
time following the initial reaction, and is down to less
than 10% after 10 years. This is because of waning
penicillin-specific IgE levels in the absence of antigenic
stimulation. A new course of penicillin in this situation
may provoke IgE production again by the memory B
cells. Skin testing with penicillin can theoretically
also restimulate IgE synthesis. It is therefore important
to tell patients that a negative skin test does not
(Continued on page 66)
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guarantee any safety to take repeated courses of
penicillin; retesting is required before each subsequent
course of penicillin. It is best to perform skin testing
just before the course of antibiotics is needed. Since
anaphylaxis is a first dose phenomenon, the danger is
minimal after the first dose of a course is tolerated,
as long as there is no interruption in treatment. An
in te r rup t ion of 3 days or longer runs the risk of
resensitisation and subsequent reaction when the course
of treatment is resumed.
The issue of cross-reactivity between penicillins
and cephalosporins is less clear. Both classes of drugs
contain a (3-lactam r ing s t ructure . Some studies
suggested that increased hypersensi t ivi ty to first-
generation cephalosporins exists in those patients who
have histories of penic i l l in allergy.8 However, these
studies were not supported by skin-test results. The
incidence of cross-reactivity between penici l l in and
second- and third- generation cephalosporins appears
to be low.9 Cross-react ivi ty between pen ic i l l ins and
cephalosporins with s imilar side chains appears to be
more frequent. Miranda reported that in 21 patients
allergic to a m o x i c i l l i n , 8 (38%) also reacted to
cefadroxil, but none reacted to cefamandole.10 If a
cephalosporin is used in a penicillin allergic patient,
inclusion of the drug in the skin test panel is advisable.
In a patient with known allergy to a cephalosporin,
another cephalospor in wi th a d i f ferent side cha in
structure is usual ly safe. Imipenem, a carbipenem
antibiot ic widely used in hospi ta ls in Hong Kong,
carries a 50% risk of cross reactivity with penicillin."
Aztreonam, a monobactam, does not cross-react with
penicil l in.1 2
In summary, if a patient with a history of penicillin
allergy requires antibiotics, subst i tut ing a chemically
unrelated antibiotic should be the first course of action.
If penicillin is absolutely required, skin testing with
major and minor determinants and amoxic i l l in will
reliably assess the risk of a serious reaction. If the
patient 's skin test is negat ive, a test dose of oral
amoxicillin should be given under medical supervision
and the patient observed for one hour before starting
the course of treatment. The patient must understand
that skin test ing w i l l only predict anaphylac t ic
reactions and minor skin rashes may still occur. If
the pat ient ' s skin test is posi t ive , an alternative
a n t i b i o t i c should be used. Unde r except ional
circumstances where penicillin is absolutely necessary,
e.g. tertiary syphilis, the patient can be desensitised.
Desens i t i sa t ion can be achieved by the oral or
intravenous methods. In both methods, the patient is
given minute doses of the (5-lactam drug starting at
0.05 mg orally or 0.01mg intravenously. The next
higher dose is given after a 15-minute interval if there
is no reaction. The dose is gradually increased over
the next 4 hours unti l the patient can tolerate a full
therapeutic dose of the drug. This should be carried
out by an allergist experienced with the procedure
under strict medical observation. After desensitisation,
treatment must begin immediately and must not be
interrupted. After a successful course of treatment,
the patient must be desensitised again jus t before
subsequent courses of penicill in in the future.
Aspirin and other NSAIDs
NSAIDs are some of the most frequently prescribed
drugs in the world. They are also hidden components
of m a n y ove r - the -coun te r cold and flu remedies .
Allergic reactions to NSAIDs are common and involve
many d i f f e r e n t m e c h a n i s m s . They can cause
exacerbation of rhinitis and asthma in patients with
aspirin sensit ive asthma. They may also exacerbate
symptoms in pat ients with idiopathic ur t icar ia and
angioedema. True immune-mediated allergic reactions
to NSAIDs also lead to ur t icar ia , angioedema and
anaphylaxis . Lastly, these drugs may rarely cause
aseptic meningit is and pneumonitis .
Up to 15% of adult asthmatics have been estimated
to have aspirin sensitive asthma (ASA). ASA is a
distinct disease entity. The typical patient with ASA
is an adult of either sex aged 20 to 40, suffering from
asthma, rhinitis, sinusitis and nasal polyps.13 Anosmia
is frequently found as is sinus opacification on x-ray.
The lower airway is sometimes spared but most patients
have moderate to severe asthma, they require high dose
inhaled corticosteroids or even oral corticosteroids.
The severity of asthmatic symptoms appears to parallel
the severity of rhinosinusitis, as treatment of the sinus
disease, e.g. by surgery, will also improve asthma
control. Improvement after surgery is usually short-
lived as nasal polyps and sinusitis tend to recur.
The hallmark of this disease is the exacerbation
of as thma wi th in 15 min to 3 hours of NSAID
ingestion. Patients may develop conjunc t iv i t i s ,
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rhinorrhoea, nasal congestion, a slow and sustained
bronchoconstriction and occasionally laryngospasm.
These reactions may last 1 to 24 hours. This is
followed by a refractory period of 2 to 5 days when
patients can take NSAIDs without any reaction. The
aetiology of this disease is known to be a disorder of
leukotr iene synthesis. The cysteinyl-leukotrienes
leukotriene C4 (LTC4) and LTD4 are the most potent
naturally-occurring bronchoconstrictors known, and can
also mediate eosinophilic inflammation. ASA patients
produce increased amounts of LTC4 and LTD4, reflected
by the raised levels of urinary LTE., (breakdown product
of LTC4 and LTD4) as compared to control asthmatics.
The urinary LTE4 is substantially increased after aspirin
challenge in ASA subjects but not control asthmatics.14
Their bronchial responsiveness to inhaled LTE4 is also
higher than non-ASA asthmatics.15
The diagnosis of ASA can be confirmed by nasal
l y s i n e - a s p i r i n cha l lenge , inha led l y s i n e - a s p i r i n
challenge or oral aspirin challenge. Nasal challenge
test is less reliable but is useful in diagnosing aspirin-
sensitive upper airway disease. Inhaled lysine-aspirin
challenge is the test of choice for diagnosing ASA.16
It is safe, the symptoms are usually limited to the lower
airways and are rapidly reversed. Oral challenge may
produce prolonged symptoms and is therefore more
hazardous. However, oral challenge can be followed
by aspirin desensitisation. Following desensitisation,
patients can take NSAIDs indefinitely as long as the
course of treatment is not interrupted by more than 2
days . F u r t h e r m o r e , desens i t i sa t ion leads to
improvemen t in both upper and lower a i r w a y
symptoms17 and should be considered for patients with
difficulty in controlling ASA.
It is important to bear in mind that ASA is a class
effect and all strong inhibitors of cyclooxygenase will
provoke reactions in these patients. Paracetamol has
been shown to cross-react at high doses (1000 mg or
greater) in 28% of ASA patients.18 Recent anecdotal
evidence claims that nimesulide, a new COX-2-selective
inh ib i to r , does not provoke symptoms in ASA
patients.1 9 Although Zileuton, a 5-lipoxygenase
inhibitor, has been found to protect ASA patients from
aspirin-induced bronchospasm,20 this has not been
shown in clinical practice. The new anti-leukotriene
drugs, while useful in improving asthma control in ASA
patients, should not be used to enable patients to take
NSAIDs. ASA patients requiring NSAIDs should
undergo desensitisation.
Aspirin and other NSAIDs have been found to
exacerbate symptoms in some patients with idiopathic
urticaria. This is probably related to inhibition of
prostaglandin synthesis common with all NSAIDs.
However, NSAIDs can also elicit IgE-mediated
reactions leading to u r t i ca r i a , angioedema and
anaphylaxis. Since this effect is immunologically-
mediated, cross-reactivity between different NSAIDs
is low and only confined to drugs with similar chemical
structure. Unfortunately, there is no reliable test in
vivo or in vitro to confirm the diagnosis. Treatment
is by avoidance since previous attempts at desensitising
these patients have failed.
Local anaesthetics
Al le rgy to local anaes the t ics is a f requen t
complaint from patients, especially in dental practice.
The usual symptoms include flushing, tachycardia and
syncope during or immediately after injection. While
c o n t a c t d e r m a t i t i s t o t o p i c a l l y app l i ed local
anaesthetics is common, systemic allergic reactions to
these drugs are extremely rare. It is possible that some
of the reported cases were caused by reactions to
preservatives in the multidose vials. Most of the cases
were anxiety reactions, vasovagal syncope or reactions
caused by direct intravenous injections of preparations
containing adrenaline. In these situations, test by
subcutaneous injections of incremental doses of the
anaesthetic in question would be very useful in allaying
the patient's fear.21
Drugs which cause pseudoallergic reactions
Many clinicians and radiologists still believe that
allergy to radiocontrast media (RCM) is related to
allergies to iodine or even seafood. While iodine can
cause dermatitis, allergy to shellfish is caused by IgE
directed against muscle proteins, components that are
not present in any radiocontrast medium. RCMs, by
virtue of their hyperosmolar nature, can directly cause
mast cell degranulation when injected intravenously.
The use of RCM in procedures such as cystograms and
myelograms poses no risk. Patients with cardiac
disease, atopy or drug allergies, or who are taking
(3-blockers are at risk of serious reactions. A history
of prior RCM reactions increases the risk of future
reactions to 30% or greater. The use of premedications
with prednisolone 40 mg, 13, 7 and 1 hour before, and
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Key messages
1. Allergic drug reactions should be distinguished
from other forms of adverse drug reactions.
2. Allergic drug react ions are immunolog ica l ly
mediated. This requires prior exposure and the
clinical manifestations are diverse.
3. The more serious types of allergic drug reactions
such as anaphylaxis, Steven-Johnson syndrome and
toxic epidermal necrolysis should be recognised.
4. Some drugs such as radiocontrast media, opiates,
muscle relaxants, dextran and vancomycin can
cause anaphylactoid reactions by directly causing
mast cell degranulation.
5. Skin testing is u s e f u l in predicting the risk of
anaphylaxis to drugs such as penicillin in patients
with prior history of allergic reactions to those
drugs. Skin testing patients without a prior history
is not indicated.
6. In most cases, an al ternat ive drug that does not
cross-react should be subs t i tu ted . Under certain
c i rcumstances , d rug desens i t i sa t ion can be
performed.
diphenhydramine and ephedrine 1 hour before the
procedure can greatly reduce the risk of reaction.22
Premedications should be given to all patients with
prior history of RCM reactions and to other patients
without such a history but are at high risk. The newer
non-ionic RCM cause fewer reactions than their
hyperosmolar counterparts, but are substantially more
expensive. These agents should be reserved for patients
with prior history of serious reactions.
The use of vancomycin is increasing because of
the e m e r g e n c e o f the m e t h i c i l l i n - r e s i s t a n t
staphylococci. Vancomycin can cause the so-called red
man syndrome, which is related to the rate of infusion.
True IgE-mediated anaphylaxis also occurs but is much
less common. Skin testing does not predict the severity
of red man syndrome,23 but can sometimes help
distinguish IgE-mediated reactions.24 Slowing the
infusion rate is usually sufficient to control the red
man syndrome. Five hundred milligrams of the drug
can be infused over as long as 8 hours. Premedication
with corticosteroids and antihistamines are also helpful.
If all else fails, desensitisation can be attempted.
Prevention of drug allergies and the multiple drug
allergy syndrome
As mentioned previously, patients with allergy to
penicillin are 10 times more likely to become allergic
to other drugs. This susceptibility not only applies
to anaphylactic type reactions, but also extends to drug
rashes, exfo l ia t ive de rmat i t i s , tox ic epidermal
necrolysis and Stevens-Johnson syndrome. In a study
of 120 patients with antibiotic allergies, 19% were
allergic to at least one other antibiotic; 15.8% reacted
to three or more antibiotics. Forty-two percent of those
patients allergic to two or more antibiotics were allergic
to NSAIDs, in contrast to only 18% of those patients
allergic to one antibiotic. The presence of atopy was
not a risk factor for multiple drug allergies.25 It is
therefore clear that some patients are highly susceptible
to developing allergies to a large number of drugs.
Preventing drug allergy is the responsibility of
medical pract i t ioners . Frequent, short courses of
antibiotics are responsible for sensitising many patients
to these drugs. I once saw a 4-year-old girl referred
to me by a hospital paediatrician because he could not
find an antibiotic that he could use to treat the girl's
pneumonia. The girl's mother listed 21 occasions in
the past three years when the girl was given antibiotics
for the treatment of viral upper respiratory tract
infections. She was otherwise a normal healthy child
and there was no sign of immunodeficiency. By the
time she visited my clinic, she had already been
admitted three times for drug-induced anaphylaxis,
once requiring intubation. Examples such as this are
admittedly rare, but I see a fair number of patients with
antibiotic allergies caused by overuse. We must educate
our patients and ourselves when antibiotics are truly
indicated. By avoiding inappropriate use, the incidence
of drug allergies will decrease, which will ultimately
benefit our patients and prevent a lot of problems for
ourselves. •
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